Condition
Non-small Cell Lung Cancer Stage III clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Non-small Cell Lung Cancer Stage III clinical trials that are recruiting, at sites in 5 countries (most in United States (4), Spain (2), China (2)). By phase: Phase 2 (6), Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 5Countries
Newest Non-small Cell Lung Cancer Stage III clinical trials
All recruiting trials (10)
-
BL-B01D1 plus osimertinib vs osimertinib alone in unresectable EGFR-mutated NSCLC (Stage III) after chemoradiation
This trial tests whether adding BL-B01D1 to osimertinib helps people with unresectable Stage III EGFR-mutated non-small cell lung cancer who did not progress after platinum-based chemoradiation.
-
Pulmonary rehabilitation for people who survived advanced non-small cell lung cancer
This research will try an eight-week pulmonary rehabilitation program to see if it helps people with advanced non-small cell lung cancer breathe easier and have more energy.
-
Chemoradiotherapy followed by durvalumab for stage III lung cancer
This study is testing if giving a combination of chemotherapy, radiation, and the immunotherapy durvalumab can help people with stage III lung cancer who couldn't initially have surgery, to see if it improves their chances of survival.
-
Examining immune responses in advanced lung cancer patients after treatment
This study looks at how the immune system responds in patients with advanced lung cancer after they receive a combination of chemotherapy, radiation, and immunotherapy to see how these treatments work together.
-
New treatment for advanced non-small-cell lung cancer using a virus and chemotherapy
This study is testing a new treatment that combines a special virus and chemotherapy to see if it can help people with advanced lung cancer who haven't responded to previous treatments.
-
Neoadjuvant treatment for advanced lung cancer with lymph node involvement
This study is testing if a new treatment combining an immunotherapy drug and chemotherapy can help people with advanced lung cancer that has spread to lymph nodes do better before and after surgery.
-
Treatment of advanced lung cancer with Sotorasib for patients unable to undergo chemotherapy.
This study is testing if a new drug called Sotorasib can help people with advanced lung cancer who can’t have chemotherapy live longer without their disease getting worse.
-
Neoadjuvant immunotherapy for stage III non-small cell lung cancer
This study is testing a new treatment using a drug called Sintilimab, with or without chemotherapy, to see if it can shrink tumors in patients with stage III non-small cell lung cancer before they have surgery.
-
Personalized treatment for early stage non-small cell lung cancer using blood tests
This study is testing if a blood test for cancer DNA can help find leftover cancer in people with early stage lung cancer after treatment, and if giving them a specific immunotherapy can help reduce it.
-
Platform for assessing molecular testing and treatment outcomes in lung cancer patients
This study is trying to gather and analyze information about treatments and outcomes for people with lung cancer to improve care and understand their quality of life better.
Related topics
Quick answers
How many Non-small Cell Lung Cancer Stage III clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (4 trials), Spain (2 trials), China (2 trials), Netherlands (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 6, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.